Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis

Autor: Ssebambulidde, Kenneth, Bangdiwala, Ananta S, Kwizera, Richard, Kandole, Tadeo Kiiza, Tugume, Lillian, Kiggundu, Reuben, Mpoza, Edward, Nuwagira, Edwin, Williams, Darlisha A, Lofgren, Sarah M, Abassi, Mahsa, Musubire, Abdu K, Cresswell, Fiona V, Rhein, Joshua, Muzoora, Conrad, Hullsiek, Kathy Huppler, Boulware, David R, Meya, David B, Adjunctive Sertraline for Treatment of HIV-associated Cryptococc

BACKGROUND: Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal meningitis is unclear. We describe a subpopulation of in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3bc52d4d73deed983e456941a18a6eb2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis.

Autor: Chesdachai, Supavit, Engen, Nicole W, Rhein, Joshua, Tugume, Lillian, Kandole, Tadeo Kiiza, Abassi, Mahsa, Ssebambulidde, Kenneth, Kasibante, John, Williams, Darlisha A, Skipper, Caleb P, Hullsiek, Kathy H, Musubire, Abdu K, Rajasingham, Radha, Meya, David B, Boulware, David R

Publikováno v: Open Forum Infectious Diseases; Dec2020, Vol. 7 Issue 12, p1-5, 5p

Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial.

Autor: Ellis J; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda.; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK., Nsangi L; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Bangdiwala A; University of Minnesota Twin Cities, Minneapolis, Minnesota, USA., Hale G; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK., Gakuru J; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Kagimu E; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Mugabi T; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Kigozi E; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Tukundane A; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Okirwoth M; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Kandole TK; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Cresswel F; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda.; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK., Harrison TS; MRC Centre for Medical Mycology, University of Exeter, Exeter, England, UK.; Centre for Global Health, Institute for Infection and Immunity, St George's University of London, London, UK., Moore D; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK., Fielding K; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK., Meya D; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda., Boulware D; University of Minnesota Twin Cities, Minneapolis, Minnesota, USA., Jarvis JN; College of Health Sciences, Makerere University, Infectious Diseases Institute, Kampala, Uganda.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Publikováno v: Wellcome open research [Wellcome Open Res] 2024 Jun 05; Vol. 9, pp. 14. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).